Fe65 Suppresses Breast Cancer Cell Migration and Invasion through Tip60 Mediated Cortactin Acetylation

Area of Science:

• Molecular biology
• Cell biology
• Cancer research

Background:

• Fe65 is a brain-enriched adaptor protein implicated in Alzheimer's disease.
• Its function in cancer cells, particularly breast cancer, remains largely uncharacterized.

Purpose of the Study:

• To investigate the role of Fe65 in breast cancer cell migration and invasion.
• To elucidate the molecular mechanisms underlying Fe65's function in breast cancer.
• To identify potential therapeutic targets for metastatic breast cancer.

Main Methods:

• Cell migration and invasion assays were performed.
• Mechanistic studies involved investigating protein-protein interactions and post-translational modifications.
• The role of Fe65, its phosphotyrosine binding domain 1, Tip60, and cortactin was examined.

Main Results:

• Fe65 was found to suppress breast cancer cell migration and invasion.
• This suppression is mediated by the recruitment of Tip60 to cortactin via Fe65's phosphotyrosine binding domain 1.
• This interaction stimulates cortactin acetylation, inhibiting cell motility.

Conclusions:

• Fe65 plays a significant role in suppressing breast cancer cell metastasis.
• The Fe65-Tip60-cortactin pathway represents a novel mechanism in cancer cell invasion.
• Tip60 acetyltransferase is identified as a potential cytoplasmic drug target for therapeutic intervention in metastatic breast cancers.